for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

China National Medicines Corporation Ltd

600511.SS

Latest Trade

27.98CNY

Change

0.48(+1.75%)

Volume

4,880,802

Today's Range

27.37

 - 

28.35

52 Week Range

20.71

 - 

30.94

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

China National Medicines' H1 Net Profit Up 18.7% Y/Y

Aug 21 (Reuters) - China National Medicines Corp Ltd <600511.SS>::SAYS H1 NET PROFIT UP 18.7% Y/Y.

China National Medicines Says 2018 Net Profit Up 23.0 Percent Y/Y

March 21 (Reuters) - China National Medicines Corp Ltd <600511.SS>::SAYS 2018 NET PROFIT UP 23.0 PERCENT Y/Y.

China National Medicines Says 9-Month Net Profit Up 13.7 Percent Y/Y

Oct 25 (Reuters) - China National Medicines Corp Ltd <600511.SS>::SAYS 9-MONTH NET PROFIT UP 13.7 PERCENT Y/Y.

China National Medicines' JV Plans To Sell 45.2 Percent Stake In Pharma Firm

Oct 15 (Reuters) - China National Medicines Corp Ltd <600511.SS>::SAYS JV PLANS TO SELL 45.2 PERCENT STAKE IN PHARMA FIRM FOR AT LEAST 423.6 MILLION YUAN ($61.23 million).

China National Medicines Says 6-Month Net Profit Up 14.8 Percent Y/Y

Aug 23 (Reuters) - China National Medicines Corp Ltd <600511.SS>::SAYS 6-MONTH NET PROFIT UP 14.8 PERCENT Y/Y.

China National Medicines unit to set up medical supply chain management JV with partner

July 12(Reuters) - China National Medicines Corp Ltd <600511.SS>:Says co's Beijing-based unit plans to invest 12 million yuan to set up a Beijing-based medical supply chain management JV with partner, with registered capital of 20 million yuan.Says unit will hold 60 percent stake in the JV.

China National Medicines' General Manager Li Zhigang Resigns Due To Personal Reasons

July 11 (Reuters) - China National Medicines Corp Ltd <600511.SS>::SAYS GENERAL MANAGER LI ZHIGANG RESIGNS DUE TO PERSONAL REASONS.

China National Medicines Sees H1 Net Profit Up 10-20 Percent Y/Y

July 6 (Reuters) - China National Medicines Corp Ltd <600511.SS>::SAYS IT SEES H1 NET PROFIT UP 10-20 PERCENT Y/Y FROM 553.9 MILLION YUAN ($83.38 million) YEAR AGO.

China National Medicines to pay A shares div for FY 2017 on June 1

May 24 (Reuters) - China National Medicines Corp Ltd <600511.SS> ::* Says it will pay cash dividend of 0.45 yuan(before tax)/A share for 2017 to shareholders of record on May 31.* The company's shares will be traded ex-right and ex-dividend on June 1 and the dividend will be paid on June 1 .

China National Medicines says change of accounting policy

March 23(Reuters) - China National Medicines Corp Ltd <600511.SS> ::Says it changed the accounting policy due to national policy requirement.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up